- Home
- CRT vs INMB Comparison
CRT vs INMB Comparison
Compare CRT & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.83
Company Overview
Basic Information| Metric | CRT | INMB |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.5M | 49.2M |
| IPO Year | 1992 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CRT | INMB |
|---|---|---|
| Price | $8.08 | $1.83 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | 26.6K | ★ 494.4K |
| Earning Date | 03-12-2026 | 10-30-2025 |
| Dividend Yield | ★ 9.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $5,621,913.00 | $50,000.00 |
| Revenue This Year | N/A | $173.21 |
| Revenue Next Year | N/A | $12,733.99 |
| P/E Ratio | $10.81 | ★ N/A |
| Revenue Growth | N/A | ★ 19.05 |
| 52 Week Low | $7.07 | $1.38 |
| 52 Week High | $13.31 | $11.64 |
Technical Indicators
Market Signals| Indicator | CRT | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 50.49 |
| Support Level | $7.34 | $1.75 |
| Resistance Level | $8.36 | $2.30 |
| Average True Range (ATR) | 0.34 | 0.16 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 48.03 | 38.82 |
Price Performance
Historical Comparison CRT
INMB
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.